BIOLASE INC (BIOL)
US0909117022 - Common Stock
BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023
BIOL stock results show that Biolase beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biolase (NASDAQ:BIOL) just reported results for the fourth quarter of 2023.Biol...
Biolase granted extension by NASDAQ to regain compliance (NASDAQ:BIOL)
BIOLASE has been granted an extension by Nasdaq to regain compliance with Listing Rule 5550(b), which requires certain financial criteria to be met.
BIOLASE announces pricing of $7 million public offering (NASDAQ:BIOL)
BIOLASE announces the pricing of its public offering of 16 million units, with an expected gross proceeds of $7 million.
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue results for 2023 based on currently...
BIOLASE files to offer units without disclosing the amount (NASDAQ:BIOL)
BIOLASE files prospectus for proposed offering of units, containing shares of common stock and warrants, without disclosing the amount.
BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, has experienced growing demand for its robust educational offering and as a...
BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2023 honor...
BIOLASE files to sell 2.22M shares for holders (NASDAQ:BIOL)
BIOLASE filed a prospectus for the resale of up to 2.22M shares by a selling stockholder. This is not an offer to sell securities.
BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been awarded a Top Workplaces 2023 honor by Orange...
BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the successful completion of a trial program featuring the...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with...